2,2,2-trifluoroacetic acid;5-[4-[5-(trifluoromethoxy)-2-pyridinyl]phenyl]sulfanyl-2H-triazole-4-carboxylic acid
C17H10F6N4O5S — CID 155250214
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2,2,2-trifluoroacetic acid;5-[4-[5-(trifluoromethoxy)-2-pyridinyl]phenyl]sulfanyl-2H-triazole-4-carboxylic acid
2,2,2-trifluoroacetic acid;5-[4-[5-(trifluoromethoxy)-2-pyridinyl]phenyl]sulfanyl-2H-triazole-4-carboxylic acid (PubChem CID 155250214) has the molecular formula C17H10F6N4O5S and a molecular weight of 496.35 g/mol. Its IUPAC name is 2,2,2-trifluoroacetic acid;5-[4-[5-(trifluoromethoxy)-2-pyridinyl]phenyl]sulfanyl-2H-triazole-4-carboxylic acid.
Molecular Properties
| Compound Name | 2,2,2-trifluoroacetic acid;5-[4-[5-(trifluoromethoxy)-2-pyridinyl]phenyl]sulfanyl-2H-triazole-4-carboxylic acid |
|---|---|
| PubChem CID | 155250214 |
| Molecular Formula | C17H10F6N4O5S |
| Molecular Weight | 496.35 g/mol |
| Exact Mass | 496.03 |
| IUPAC Name | 2,2,2-trifluoroacetic acid;5-[4-[5-(trifluoromethoxy)-2-pyridinyl]phenyl]sulfanyl-2H-triazole-4-carboxylic acid |
| SMILES | O=C(O)C(F)(F)F.O=C(O)c1n[nH]nc1Sc1ccc(-c2ccc(OC(F)(F)F)cn2)cc1 |
| InChI | InChI=1S/C15H9F3N4O3S.C2HF3O2/c16-15(17,18)25-9-3-6-11(19-7-9)8-1-4-10(5-2-8)26-13-12(14(23)24)20-22-21-13;3-2(4,5)1(6)7/h1-7H,(H,23,24)(H,20,21,22);(H,6,7) |
| InChIKey | OCWJEYUATKMDCH-UHFFFAOYSA-N |
| XLogP | 4.25 |
| TPSA | 138.29 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 496.35 |
| LogP ≤ 5 | 4.25 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155250214 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.